BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20943354)

  • 1. [Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
    Bélien-Pallet V; Cabrol S; Fasola S; Petit A; Landman-Parker J; Auvrignon A; Leverger G
    Arch Pediatr; 2010 Dec; 17(12):1637-44. PubMed ID: 20943354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
    Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
    Rix M; Birkebaek NH; Rosthøj S; Clausen N
    J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of recovery of adrenal function in children treated for leukemia.
    Felner EI; Thompson MT; Ratliff AF; White PC; Dickson BA
    J Pediatr; 2000 Jul; 137(1):21-4. PubMed ID: 10891816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
    Petersen KB; Müller J; Rasmussen M; Schmiegelow K
    Med Pediatr Oncol; 2003 Aug; 41(2):110-4. PubMed ID: 12825213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia.
    Vestergaard TR; Juul A; Lausten-Thomsen U; Lausen B; Hjalgrim H; Kvist TK; Andersen EW; Schmiegelow K
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):442-9. PubMed ID: 21792040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agents.
    Mahachoklertwattana P; Vilaiyuk S; Hongeng S; Okascharoen C
    J Pediatr; 2004 Jun; 144(6):736-40. PubMed ID: 15192618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
    Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
    J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
    McNeer JL; Nachman JB
    Br J Haematol; 2010 Jun; 149(5):638-52. PubMed ID: 20408842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
    Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
    Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia.
    Hill G; Chauvenet AR; Lovato J; McLean TW
    Pediatrics; 2005 Oct; 116(4):e525-9. PubMed ID: 16199681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.
    Kuperman H; Damiani D; Chrousos GP; Dichtchekenian V; Manna TD; Filho VO; Setian N
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2993-6. PubMed ID: 11443157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.
    Belgaumi AF; Al-Bakrah M; Al-Mahr M; Al-Jefri A; Al-Musa A; Saleh M; Salim MF; Osman M; Osman L; El-Solh H
    Cancer; 2003 Jun; 97(11):2898-903. PubMed ID: 12767105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency and risk factors of biological adrenal insufficiency screened by the 250 microg Synacthene stimulation test after a prolonged course of systemic glucocorticoid therapy. A study of 100 patients].
    Pugnet G; Sailler L; Astudillo L; Vernet J; Bennet A; Arlet P
    Rev Med Interne; 2010 May; 31(5):332-6. PubMed ID: 20416989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-induced glaucoma in children with acute lymphoblastic leukemia: a possible complication.
    Yamashita T; Kodama Y; Tanaka M; Yamakiri K; Kawano Y; Sakamoto T
    J Glaucoma; 2010 Mar; 19(3):188-90. PubMed ID: 19661822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effects of steroids revisited.
    Brook CG
    J Pediatr; 2000 Jul; 137(1):3-4. PubMed ID: 10891811
    [No Abstract]   [Full Text] [Related]  

  • 17. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
    Mitchell CD; Richards SM; Kinsey SE; Lilleyman J; Vora A; Eden TO;
    Br J Haematol; 2005 Jun; 129(6):734-45. PubMed ID: 15952999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
    Athale UH; Siciliano SA; Crowther M; Barr RD; Chan AK
    Br J Haematol; 2005 Jun; 129(6):803-10. PubMed ID: 15953008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
    Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity after successful treatment of acute lymphoblastic leukemia in childhood.
    Van Dongen-Melman JE; Hokken-Koelega AC; Hählen K; De Groot A; Tromp CG; Egeler RM
    Pediatr Res; 1995 Jul; 38(1):86-90. PubMed ID: 7478803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.